IONTOPHORESIS OF LI+ ANTAGONIZES NORADRENERGIC SYNAPTIC INHIBITION OF RAT CEREBELLAR PURKINJE-CELLS

被引:24
作者
SIGGINS, GR
HENRIKSEN, SJ
BLOOM, F
机构
关键词
D O I
10.1073/pnas.76.6.3015
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Li salts provide effective therapy for manic-depressive psychosis, but the site and mechanism of this effect are not known. We have tested the ability of Li, applied by microiontophoresis, to modify the responsiveness of rat cerebellar Purkinje neurons to iontophoretic applications of norepinephrine and γ-aminobutyrate and to the inhibition produced by stimulation of the noradrenergic ceruleo-cerebellar pathway. As previously reported for rat hippocampal neurons, acute exposure to Li produces selective, reversible antagonism of the effects of norepinephrine and the noradrenergic pathway but does not affect inhibitory actions of γ-aminobutyrate. Collectively, these selective antagonisms of noradrenergic synaptic inhibitions in the cerebellum and hippocampus man indicate a general effect of Li suitable for extended observations in rats exposed to Li for the chronic periods needed to achieve therapeutic effects in man.
引用
收藏
页码:3015 / 3018
页数:4
相关论文
共 28 条
[1]  
[Anonymous], 1967, CEREBELLUM NEURONAL, DOI 10.1007/978-3-662-13147-3
[2]  
BLOOM FE, 1978, PSYCHOPHARMACOLOGY G, P131
[3]  
BUNNEY WE, 1975, PSYCHOPHARMACOL COMM, V1, P599
[4]  
BUNNEY WE, 1976, NEUROSCI RES PROG B, V14, P111
[5]  
COOMBS HI, 1975, LITHIUM RES THERAPY, P165
[6]  
DAVIS JM, 1976, AM J PSYCHIAT, V133, P1
[7]  
DOUSA T, 1970, LANCET, V1, P834
[8]   KINETIC AND EQUILIBRIUM COMPONENTS OF SELECTIVE IONIC PERMEABILITY MEDIATED BY NACTIN-TYPE AND VALINOMYCIN-TYPE CARRIERS HAVING SYSTEMATICALLY VARIED DEGREES OF METHYLATION [J].
EISENMAN, G ;
KRASNE, S ;
CIANI, S .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1975, 264 (DEC30) :34-60
[9]   EFFECTS OF LITHIUM ON BRAIN ADENYL CYCLASE ACTIVITY [J].
FORN, J ;
VALDECASAS, FG .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (10) :2773-+
[10]  
FREEDMAN R, 1976, BRIT J PHARMACOL, V55, P43